Small Molecule mRNA Biology Modulators
Anima Biotech is transforming target and drug discovery with a unique Visual Biology approach, with pipeline of small molecule mRNA biology modulators, addressing hard-to-drug areas traditional approaches can't reach:
- Immunology: Lung fibrosis candidate advancing in preclinical stage.
- Oncology: Solid tumor lead compounds entering preclinical stage, with additional programs targeting Lymphoma and Neuroblastoma.
- Neuroscience: Alzheimer's disease and Pain management.
With 20+ programs advancing across our internal pipeline and partnerships with AbbVie, Takeda, and Lilly, we are actively exploring new collaborations. Let’s partner: [email protected]
Indication | Target | Discovery |
Optimization |
Preclinical |
|
---|---|---|---|---|---|
Immunology |
|||||
Lung fibrosis | 1 | ||||
Multiple fibrosis | 2 | ||||
Multiple fibrosis | 3 | ||||
Undisclosed | ![]() |
4 | |||
Oncology |
|||||
Solid tumors | 5 | ||||
Solid tumors | 6 | ||||
Leukemia | 7 | ||||
Neuroblastoma | 8 | ||||
Solid tumors | 9 | ||||
Undisclosed | ![]() |
10 | |||
Undisclosed | 11 | ||||
Neuroscience |
|||||
Alzheimer | 12 | ||||
Pain | 13 | ||||
Undisclosed | 14 | ||||
Undisclosed | ![]() |
15 | |||
Undisclosed | 16 | ||||
Huntington | 17 | ||||
Undisclosed | ![]() |
18 | |||
Undisclosed | 19 | ||||
Undisclosed | 20 |
Area | Indication | Target | Discovery |
Optimization |
Preclinical |
||
---|---|---|---|---|---|---|---|
Immunology | Lung fibrosis | 1 | |||||
Multiple fibrosis | 2 | ||||||
Multiple fibrosis | 3 | ||||||
Undisclosed | ![]() |
4 | |||||
Oncology | Solid tumors | 5 | |||||
Solid tumors | 6 | ||||||
Leukemia | 7 | ||||||
Neuroblastoma | 8 | ||||||
Solid tumors | 9 | ||||||
Undisclosed | ![]() |
10 | |||||
Undisclosed | 11 | ||||||
Neuroscience | Alzheimer | 12 | |||||
Pain | 13 | ||||||
Undisclosed | 14 | ||||||
Undisclosed | ![]() |
15 | |||||
Undisclosed | 16 | ||||||
Huntington | 17 | ||||||
Undisclosed | ![]() |
18 | |||||
Undisclosed | 19 | ||||||
Undisclosed | 20 |